Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

50.95
-1.7500-3.32%
Post-market: 50.950.00000.00%17:12 EDT
Volume:1.79M
Turnover:91.37M
Market Cap:7.94B
PE:98.12
High:53.60
Open:52.62
Low:50.56
Close:52.70
52wk High:72.16
52wk Low:46.01
Shares:155.81M
Float Shares:154.93M
Volume Ratio:0.93
T/O Rate:1.15%
Dividend:0.32
Dividend Rate:0.63%
EPS(TTM):0.5193
EPS(LYR):0.4600
ROE:3.97%
ROA:6.52%
PB:3.95
PE(LYR):110.76

Loading ...

Stock Track | Bio-Techne Soars 5.14% in Pre-Market on Strong Q2 Earnings Beat and China/APAC Growth

Stock Track
·
Feb 04

Bio-Techne Shares up 2.54% After Q2 Results Beat Estimates

THOMSON REUTERS
·
Feb 04

BUZZ-U.S. STOCKS ON THE MOVE-Bio-Techne, AbbVie, Johnson Controls

Reuters
·
Feb 04

Bio-Techne Exec Says Modest Decline in Co's US Academic Business Was Partially Offset by Stable Growth in Europe - Conf Call

THOMSON REUTERS
·
Feb 04

Stock Track | Bio-Techne Soars 5.04% in Pre-Market on Better-Than-Expected Quarterly Results

Stock Track
·
Feb 04

Bio-Techne Declares Quarterly Dividend of $0.08 a Share, Payable Feb. 27 to Shareholders of Record on Feb. 16

MT Newswires Live
·
Feb 04

Biotech firm Bio-Techne beats quarterly estimates on strength in key unit

Reuters
·
Feb 04

Bio-Techne Q2 revenue, adjusted EPS beat estimates on China/APAC growth

Reuters
·
Feb 04

Bio-Techne meldet für das zweite Quartal ein bereinigtes Ergebnis je Aktie von 0,46 USD mit einem Anstieg von 9,5 Prozent

Reuters
·
Feb 04

BRIEF-Bio-Techne Q2 Adjusted EPS USD 0.46 Vs. IBES Estimate USD 0.43

Reuters
·
Feb 04

Bio-Techne Corporation announces $0.08 quarterly dividend

Reuters
·
Feb 04

Bio-Techne Corp - Announces Dividend of $0.08 per Share for Q4 2025

THOMSON REUTERS
·
Feb 04

Bio-Techne Q2 Pretax Profit USD 50.784 Million

THOMSON REUTERS
·
Feb 04

Bio-Techne Releases Second Quarter Fiscal 2026 Results

THOMSON REUTERS
·
Feb 04

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 03

Bio-Techne Launches Cultrex Synthetic Hydrogel to Support 3D Stem Cell, Organoid Research

MT Newswires Live
·
Feb 02

BRIEF-Bio-Techne Expands 3D Stem Cell & Organoid Culture Portfolio

Reuters
·
Feb 02

Bio-Techne launches Cultrex Synthetic Hydrogel

TIPRANKS
·
Feb 02

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio With a Fully Defined Synthetic Alternative

THOMSON REUTERS
·
Feb 02

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 29